REDHILL BIOPHARMA LTD. Amortisation Expense
REDHILL BIOPHARMA LTD. (RDHL) reported Amortisation Expense of $16.00 thousand for the 6-month period ending 2025-06-30, per its 6-K filed 2025-09-05.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:AmortisationExpense · last filed 2025-09-05
| Period end | Amortisation Expense 6 month | Amortisation Expense 12 month |
|---|---|---|
| 2025-06-30 | $16.00K 6-K · filed 2025-09-05 | |
| 2024-12-31 | $31.00K 20-F · filed 2025-04-10 | |
| 2024-06-30 | $16.00K 6-K · filed 2025-09-05 | |
| 2023-12-31 | $545.00K 20-F · filed 2025-04-10 | |
| 2022-12-31 | $6.02M 20-F · filed 2025-04-10 |